• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Can a top scientist and Moderna co-founder change the CRO game?

cafead

Administrator
Staff member
  • cafead   Feb 28, 2024 at 11:12: AM
via When you’re looking to make changes to biopharma clinical trials, one of the top minds in the industry could help you get there — by welcoming Robert Langer to its advisory board, that’s exactly what Lindus Health aims to do.

article source